Abstracts Submission

TOP > Abstracts Submission

JSCO 2024 welcomes your abstract submission for free papers at the 62nd Annual Meeting in October 24-26, 2024.

 

Important Notice

JSCO2024 is going to be held as an onsite congress.
Please be noted that presenters are required to be present at the venue on the day of their presentation. Otherwise, the abstract will be automatically withdrawn from the program.

 

Submission Period

Abstract Submission for Free papers:
February 14 (Wed)
-
Noon, April 24 (Wed) , 2024 JST

 

Abstract Submission for Invited Speakers:
 Will be announced through email individually.

 

Submission Requirements (Free Papers)

  • The first author should be a member of JSCO to submit abstract, however this does not apply to the invited speakers, the overseas, the medical staff and students. Thus JSCO2024 also welcome abstracts from all those non-members.

     

    ※To become a member of the Japan Society of Clinical Oncology (JSCO)

    If you wish to become a member of JSCO, please visit the JSCO website  for further details.

    Contact: Secretariat of the Japan Society of Clinical Oncology
    E-mail:office@jsco.or.jp

 

Submission Method

All abstracts should be submitted through the online abstract submission system. We suggest you to have enough time for abstract submission since the line may be busy a few days before the submission deadline.

 

※About Abstract Submission System
 JSCO has introduced an abstract submission system for both general and invited speakers starting from JSCO 2014 Congress. This system enables JSCO members to obtain their registered membership data from "My Ganchi" system and reduce time to input personal information when registering abstracts.
 JSCO members are requested to check the registered membership data and update as necessary.

 

Submission Process

 1. JSCO Members and Applicants 

Step 1 Click the button marked as "Online Abstract Submission System" at the bottom of this page, and access to the system.
Step 2 Enter your 5 digit Membership No., Login ID, and Password used when logging-in to "my ganchi" system. Then, click "Sign in" button.
※For those applying for membership, enter your temporary ID (TMP + 5 digits number) as Membership No.
Step 3 Check your information in "Your Profile" and "Head Author's Information" sections, and submit your abstract.
Step 4 Once the abstract registration completes, a confirmation email will be sent to your registered email address.
If you do not receive a confirmation email within 30 minutes, please contact the Management Secretariat at jsco2024-abs@congre.co.jp.

If you have forgotten your Login ID and Password used for "my ganchi" system, please click here .

 

 2. JSCO Non-Members (Overseas, Medical Staff, Student)

Step 1 Click the button marked as "Online Abstract Submission System" at the bottom of this page, and access to the system.
Step 2 Click "Registration as the first author" in Non-Members category located at the bottom of Top page, and open the registration page.
Step 3 Enter your personal information on "Create a New Account" page.
Step 4 Once the personal information registration is completed, a message for completion will be shown on the screen together with your 1)ID for Abstract Submission, 2)Log-in ID, 3)Password.
Also, a confirmation email titled "My Account / Confirmation" will be sent to your registered email address. If you do not receive a confirmation email within 30minutes, please contact the Management Secretariat at jsco2024-abs@congre.co.jp.
Step 5 By clicking the button of "to TOP Page" at the foot of Registration Completion Page (mentioned on STEP 4 above), or by entering newly issued IDs and Password from Top page, you can confirm your personal information and enter your abstracts.
Step 6 Once the abstract registration is completed, a message for completion will be shown together with your ①ID for Abstract Submission, ②Log-in ID, ③Password on the screen. Also, a confirmation email will be sent to your registered email address. If you do not receive a confirmation email within 30minutes, please contact the Management Secretariat at jsco2024-abs@congre.co.jp.

For security reasons, we are unable to answer any questions about your passwords.

 

 ■Invited Speakers

Step 1 Please access to the URL indicated in the email sent from the Management Secretariat, and enter your Access ID, Login ID, and Password. Then, click "Sign in" button.
Step 2 Please check your information in "Your Profile" and "Head Author's Information" sections. Click "Biography" button to enter your biography, and click "Abstract Submission for Invited Speakers" button for submission of abstract.
Step 3 Once the abstract registration is completed, a confirmation email will be sent to your registered email address. If you do not receive a confirmation email within 30minutes, please contact the Management Secretariat at jsco2024-abs@congre.co.jp.

 

Presentation Style

  1. General Abstracts
  Abstract Presentation Slides Presentation Language
Doctors English English English or Japanese
Non-doctors English English or Japanese English or Japanese
※All doctors are requested to submit abstracts in English.
  • The presentation will be in the form of an oral or poster presentation, and it will be left to the Congress President and the Program Committee Members' discretion.
(1) Oral Presentation
  • Please make a PC-based presentation.
(2) Poster Presentation
  • In order to avoid gatherings during the poster panel presentations, all presentations will be paper based poster presentation. All e-poster data should be submitted in advance. More details regarding e-poster presentations will be announced at a later date.

 

Important Notes for Submission

  • Items marked with "* asterisk" are required information. If you do not complete the required information, you will not be able to proceed to registration.
  • Please answer the questions in each page, including COI Disclosure, Personal Information, Agreement on Submission, and Copyright.
  • Limitation for Registration
  Doctors Non-doctors
Total number of Authors
(first author and
co-authors)
Up to 15 authors Up to 15 authors
Total number of Affiliations Up to 15 affiliations Up to 15 affiliations
Total number of characters
for Abstract Title
English: Up to 200 characters
(including spaces)
English: Up to 200 characters
(including spaces)
Total number of characters
for Abstract Body
English: Up to 2,000 characters
(including spaces)
English: Up to 2,000 characters
(including spaces)
Presentation Language English or Japanese English or Japanese

 

Disclosure of COI (Conflict of Interest)

Industry-academic collaborative clinical oncology research entails benefits to society (public interest) from the fruits of discharging academic and ethical responsibility, as well as money, status, rights, and other benefits (private interest) acquired attendant on industry-academic collaboration. When these two types of benefit are in conflict within an individual researcher, it is called a “conflict of interest.” The occurrence of conflict of interest is unavoidable in today’s complex social activities, and legal restrictions apply to certain activities.

 

Click here for details >> Disclosure of COI 

 

Categories

(1) Speciality
01
Internal medicine
02
Surgery
03
Obstetrics & Gynecology
04
Radiology
05
Urology
06
Orthopedics
07
Oral surgery
08
Ophthalmology
09
Otolaryngology
10
Dermatology
11
Pediatric
12
Anesthesiology
13
Neurosurgery
14
Plastic surgery
15
Basic medicine
16
Clinical pathology
17
Neuropsychiatry
18
Palliative medicine
19
Pharmacology
20
Nursing

 

(2) Areas of Research : Classified by Organ, etc.
01
Pediatrics
02
Neurologic
03
Eyes
04
Oral Cavity
05
Head and Neck
06
Breast
07
Esophagus
08
Stomach / Duodenum
09
Small / Large Intestine
10
Liver
11
Gallbladder / Biliary Tract
12
Pancreas
13
Lung / Mediastinum / Pleura
14
Uterus
15
Ovary
16
Kidney / Urinary Tract / Bladder
17
Prostate / Male Genital
18
Endocrine
19
Skin
20
Bone and Soft Tissue
21
Hematopoietic Organs / Lymphatic System
22
NET (Neuroendocrine Tumor)
23
Rare cancer related gene mutations
24
Others

 

(3) Technique
01
Epidemiology and Prevention
02
Pathology
03
Basic Oncology
04
Genomic Gene
05
Tumor Immunity
06
Diagnosis
07
Genetic Diagnosis
08
Imaging
09
Sensitivity Test
10
Biomarkers
11
Translational Research
12
Clinical Trial
13
Guide Line
14
Endoscopic Treatment
15
Surgical Techniques
16
Endoscopic Surgery
17
Chemical Treatment
18
Targeted Therapy
19
Endocrine Hormone Therapy
20
Immunotherapy
21
Transplantation and Cellular Therapy
22
Gene Therapy
23
Radiation Therapy
24
IVR (Interventional radiology)
25
Topical Therapy
26
Intensive Treatment
27
Supportive Therapy
28
Palliative Therapy
29
QOL
30
Team Medical Care
31
Cancer Nursing
32
Rehabilitation
33
Patient Support, Survivorship
34
Oncofertility
35
Regional Collaboration
36
Health Economics
37
Health Policy
38
Medical Equipment and Medical Engineering
39
Regenerative Medicine
40
AI
41
Medical data science
42
COVID-19
43
Others

 

Excellent Abstracts & Best Abstracts Awards

The Congress President and the Program Committee will select excellent abstracts from the submitted general abstracts. The best abstracts will then be chosen from those selected abstracts. The head authors of the best abstracts are requested to make an oral presentation at the Plenary Session either in English or Japanese.

 

  • The Congress President and the Program Committee will select excellent abstracts by thoroughly reviewing the submitted general abstracts.
  • The head authors whose abstracts have been selected as excellent abstracts are required to submit the abstract in English, in case the submitted abstracts are in Japanese.
  • The excellent abstracts will be posted on the JSCO website.
    On the page for public: Authors' name, affiliation and abstract
    On the page for JSCO members: Authors' name, affiliation, abstract and presentation slides

 

Result of Abstract Acceptance & Program Allocation

The presentation style will be decided by the Congress President and the Program Committee Members. Please kindly note that we sometimes may not be able to meet your preference.

 

Notification for Acceptance/Rejection of Abstracts, Presentation Style & Date/Time

The notification of the abstracts result, presentation style, date and time will be sent to the first authors' registered email address from the Management Secretariat (jsco2024-abs@congre.co.jp) at late August.

 

Copyright of Accepted Abstracts

The copyright of all accepted abstracts will be transferred to JSCO.
The abstracts submitted by the invited speakers will be posted on the JSCO website .

 

Online Abstract Submission System

Click the button below to start your abstract submission.
Please note in advance that you will not be able to save the data in middle of the submission procedure.

 

Inquiries for Abstract Submission

c/o Congrès Inc.
Onward Park Building, 3-10-5 Nihonbashi, Chuo-ku, Tokyo 103-8276, Japan
E-mail:jsco2024-abs@congre.co.jp